Elevance Health, Inc. (ELV)
Elevance Health, Inc. reported revenue of $199.12B for the fiscal year ended Dec 31, 2025, up 12.5% from $177.01B the year before. Net income was $5.66B, a net margin of 2.8% (prior year: $5.98B). At the end of that fiscal year the company reported total assets of $121.49B and shareholders' equity of $43.88B.
Revenue
$199.12B
+12.5% vs prior year
Net income
$5.66B
Net margin 2.8%
Diluted EPS
$25.21
USD per share
Total assets
$121.49B
At Dec 31, 2025
Equity
$43.88B
At Dec 31, 2025
Shares outstanding
216M
As of Oct 15, 2026
Explore Elevance Health, Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 21, 2026
- 10-QFiled Jul 15, 2026
- 10-QFiled Apr 22, 2026
- 10-KFiled Feb 6, 2026
- 10-QFiled Oct 21, 2025
- 10-QFiled Jul 17, 2025
Compare Elevance Health, Inc.
- UNHUNH vs ELV
Source: SEC EDGAR XBRL company facts for CIK 1156039 (raw data). Most recent filing in this dataset: 10-Q filed Oct 21, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.